TFS Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-106,319
| Closed | -$1.27M | – | 1092 |
|
|
2016
Q1 | $1.27M | Buy |
+106,319
| New | +$1.27M | 0.18% | 186 |
|
|
2015
Q4 | – | Sell |
-22,425
| Closed | -$241K | – | 833 |
|
|
2015
Q3 | $241K | Sell |
22,425
-6,882
| -23% | -$74K | 0.02% | 703 |
|
|
2015
Q2 | $236K | Buy |
+29,307
| New | +$236K | 0.02% | 720 |
|
|
2014
Q4 | – | Sell |
-16,584
| Closed | -$164K | – | 1079 |
|
|
2014
Q3 | $164K | Buy |
16,584
+3,880
| +31% | +$38.4K | 0.01% | 919 |
|
|
2014
Q2 | $143K | Buy |
+12,704
| New | +$143K | 0.01% | 1012 |
|
|
2014
Q1 | – | Sell |
-23,637
| Closed | -$298K | – | 1481 |
|
|
2013
Q4 | $298K | Sell |
23,637
-9,064
| -28% | -$114K | 0.01% | 1099 |
|
|
2013
Q3 | $545K | Buy |
32,701
+5,554
| +20% | +$92.6K | 0.02% | 832 |
|
|
2013
Q2 | $412K | Buy |
+27,147
| New | +$412K | 0.02% | 984 |
|